SCHEMBL23772953

SCHEMBL23772953

CCCSc1nc(Cl)c(NC)c(N(C=O)Cc2ccccc2)n1

nearest known ligand 0.38

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 1/20 0.37
▸ RAB9A P51151 1/20 0.36
▸ CTSB P07858 1/20 0.36
▸ ADORA3 P0DMS8 4/20 0.36
▸ ADORA1 P30542 4/20 0.36
▸ TLR7 Q9NYK1 1/20 0.35
▸ ABL1 P00519 2/20 0.33
▸ SRC P12931 2/20 0.33
▸ ALDH1A1 P00352 2/20 0.33
▸ GLA P06280 1/20 0.33
▸ KMT2A Q03164 1/20 0.33
▸ ADORA2A P29274 1/20 0.32
▸ KDM1A O60341 1/20 0.32
▸ LMNA P02545 1/20 0.31
▸ POLB P06746 1/20 0.31
▸ MAPT P10636 1/20 0.31
▸ HTT P42858 1/20 0.31
▸ NPSR1 Q6W5P4 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21319065 0.90 MEN1 (0.36) SMN1; SMN2ADORA3TLR7ALDH1A1KMT2A
SCHEMBL21319054 0.90 ADORA3 (0.43) CTSBADORA3ADORA1TLR7ABL1
SCHEMBL21318942 0.89 KMT2A (0.34) SMN1; SMN2RAB9AADORA3TLR7ALDH1A1
SCHEMBL19945665 0.87 ABCB1 (0.38) SMN1; SMN2RAB9ACTSBADORA3ADORA1
SCHEMBL21318981 0.87 TOP2A (0.33) ADORA3MAPT
SCHEMBL21318973 0.86 — —
SCHEMBL21318976 0.85 ADORA3 (0.37) SMN1; SMN2CTSBADORA3ADORA1TLR7
SCHEMBL21318948 0.84 SRC (0.39) SMN1; SMN2CTSBADORA3ADORA1TLR7
SCHEMBL21318979 0.83 ADORA3 (0.34) SMN1; SMN2CTSBADORA3ADORA1ABL1
SCHEMBL21318940 0.80 ADORA3 (0.42) CTSBADORA3ADORA1TLR7KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3865482-A1 7-SUBSTITUTED SULFONIMIDOYLPURINONE COMPOUNDS FOR THE TREATMENT AND PROPHYLAXIS OF VIRUS INFECTION F. Hoffmann-La Roche AG (CH) 2021-08-18 — — EP disclosed
Send feedback